Sagrada, A <br/><br/>
Antiemetic activity of the new 5-HT3 antagonist DAU 6215 in animal models of cancer chemotherapy and radiation.  [electronic resource] 

 -  Cancer chemotherapy and pharmacology  1991 
 - 470-4 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0344-5704 
<br/><br/><label>Standard No.: </label>10.1007/BF00685825  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiemetics--therapeutic use<br/>Benzimidazoles--therapeutic use<br/>Bridged Bicyclo Compounds--therapeutic use<br/>Bridged Bicyclo Compounds, Heterocyclic<br/>Cisplatin--adverse effects<br/>Disease Models, Animal<br/>Dogs<br/>Dose-Response Relationship, Drug<br/>Doxorubicin--adverse effects<br/>Drug Evaluation, Preclinical<br/>Female<br/>Ferrets<br/>Imidazoles--therapeutic use<br/>Male<br/>Metoclopramide--therapeutic use<br/>Neoplasms, Experimental--complications<br/>Ondansetron<br/>Serotonin Antagonists--therapeutic use<br/>Time Factors<br/>Vomiting--etiology